The foundation has committed up to US$120 million to help ensure equitable global distribution of a promising new COVID-19 drug, molnupiravir. Here’s why that drug may be a game-changer in…
In the race against the coronavirus and its variants, wealthier countries must meet their vaccine-sharing commitments faster and pledge a greater share of their supply to low- and middle-income countries.
The foundation’s CEO addresses pressing issues for the foundation—both internally and in its work to improve lives around the world during the pandemic and beyond.
High-income countries are likely to have at least 1 billion excess COVID-19 vaccine doses this year. Sharing those doses can help save lives and bring the pandemic under control.
Women’s funds have long been on the front lines of addressing persistent societal injustices. They need our support to address the harms suffered by women during the COVID-19 pandemic—from lost…
Rodger Voorhies, president of the foundation’s Global Growth & Opportunity Division, discusses efforts to help farmers adapt to climate change in countries that are already being affected by rising temperatures.
Dr. Mike McCune, head of the foundation’s HIV Frontiers Program, details a groundbreaking new partnership with Novartis to develop affordable, single-dose gene therapies for people infected with sickle cell disease…
As Mark Suzman marks one year as CEO, he answers questions from readers of The Optimist about global health in the era of COVID-19 and how the pandemic has affected…
